Guy Wouters

Title: Guy Wouters: Innovator in Cryopreservation Technology

Introduction

Guy Wouters is a notable inventor based in Putte, Belgium. He has made significant contributions to the field of cryopreservation, particularly in the isolation of mesenchymal stem cells. His innovative approach aims to enhance the viability of stem cells derived from adipose tissue, which has important implications for medical applications.

Latest Patents

Wouters holds a patent for his invention titled "Cryopreservation of adipose tissue for the isolation of mesenchymal stem cells." This patent describes a method and composition for cryopreserving adipose tissue, ensuring that the tissue remains viable for culturing stem and/or progenitor cells. The method utilizes a specific cryoprotection medium that prevents damage to the original tissue during the cryopreservation process. Notably, this medium does not contain any xenogeneic sera, which is crucial for the intended medical use of the cryopreserved tissue. The cryoprotection medium consists of a solution of physiological water containing glycerol and sucrose and/or trehalose, and optionally serum albumin. Wouters' innovative method is a significant advancement in the field of regenerative medicine.

Career Highlights

Guy Wouters is associated with Cryo-Save AG, a company that specializes in stem cell storage and related technologies. His work at Cryo-Save AG has allowed him to focus on developing methods that improve the preservation and viability of stem cells, which are essential for various medical treatments.

Collaborations

Wouters has collaborated with notable colleagues, including Kelly Van Wemmel and Peter De Waele. These collaborations have contributed to the advancement of research in cryopreservation and stem cell technology.

Conclusion

Guy Wouters is a pioneering inventor whose work in cryopreservation has the potential to transform the field of regenerative medicine. His innovative methods for preserving adipose tissue and isolating stem cells are crucial for future medical applications.